LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

por Shi, Qianfeng, Li, Yudong, Li, Shunying, Jin, Liang, Lai, Hongna, Wu, Yanqing, Cai, Zijie, Zhu, Mengdi, Li, Qian, Li, Ying, Wang, Jingru, Liu, Yujie, Wu, Zongqi, Song, Erwei, Liu, Qiang
Publicado 2020

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

por Zhu, Yinghua, Liu, Yujie, Zhang, Chao, Chu, Junjun, Wu, Yanqing, Li, Yudong, Liu, Jieqiong, Li, Qian, Li, Shunying, Shi, Qianfeng, Jin, Liang, Zhao, Jianli, Yin, Dong, Efroni, Sol, Su, Fengxi, Yao, Herui, Song, Erwei, Liu, Qiang
Publicado 2018

LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein

por Cai, Zijie, Shi, Qianfeng, Li, Yudong, Jin, Liang, Li, Shunying, Wong, Lok Lam, Wang, Jingru, Jiang, Xiaoting, Zhu, Mengdi, Lin, Jinna, Wang, Qi, Yang, Wang, Liu, Yujie, Zhang, Jun, Gong, Chang, Yao, Herui, Yao, Yandan, Liu, Qiang
Publicado 2023

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy

por Li, Shunying, Lai, Hongna, Liu, Jieqiong, Liu, Yujie, Jin, Liang, Li, Yudong, Liu, Fengtao, Gong, Yuhua, Guan, Yanfang, Yi, Xin, Shi, Qianfeng, Cai, Zijie, Li, Qian, Li, Ying, Zhu, Mengdi, Wang, Jingru, Yang, Yaping, Wei, Wei, Yin, Dong, Song, Erwei, Liu, Qiang
Publicado 2020